Related Experiment Video
Updated: Jul 15, 2026
10:57
Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Vitamin E status of US children
1Human Nutrition Research, Hoffmann-LaRoche Inc., Nutley, New Jersey.
Journal of the American College of Nutrition
|August 1, 1992
Summary
American children often have inadequate vitamin E intake, potentially impairing immune function and increasing chronic disease risk. Ensuring sufficient vitamin E is crucial for both children and adults to prevent long-term health issues.
Area of Science:
- Nutritional Science
- Pediatric Health
- Public Health
Background:
- National surveys reveal suboptimal vitamin E intake among American children.
- Reduced dietary fat intake can worsen vitamin E status in pediatric populations.
- Low vitamin E levels are linked to various health concerns in both children and adults.
Purpose of the Study:
- To highlight the prevalence of low vitamin E intake in American children.
- To discuss the potential health consequences of inadequate vitamin E.
- To emphasize the importance of adequate vitamin E intake across all age groups.
Main Methods:
- Analysis of data from national surveys on nutrient intake.
- Review of studies correlating vitamin E status with health outcomes.
- Examination of pediatric autopsy findings for signs of chronic disease.
Main Results:
- Consistent data show lower-than-recommended vitamin E intakes in American children.
- Low vitamin E status is associated with impaired immune responses in children.
- In adults, low vitamin E is linked to increased risks of cardiovascular disease, cancer, and cataracts.
Conclusions:
- Prolonged low vitamin E intake poses significant health risks, particularly for children.
- Early signs of age-related chronic diseases are observable in childhood.
- Strategies to ensure adequate vitamin E intake are essential for public health.
More Related Videos
08:38Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
03:19Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...